ASTRO

Proton International and Beaumont Health Open Michigan's First Proton Therapy Facility
News | Proton Therapy | July 17, 2017

July 17, 2017 — Proton International (PI) and Beaumont Health recently opened the state’s first...

Varian Receives FDA 510k Clearance for Halcyon Treatment System
Technology | Intensity Modulated Radiation Therapy (IMRT) | July 05, 2017

July 5, 2017 — Varian Medical Systems has received U.S. Food and Drug Administration (FDA) 510(k) clearance for the...

Surgery and High-Dose SBRT Radiation Can Be Combined to Treat Kidney Cancer
News | Stereotactic Body Radiation Therapy (SBRT) | July 05, 2017

July 5, 2017 — A new study from Roswell Park Cancer Institute reporting the findings of the first clinical trial to...

First New York Metropolitan Hospital Treats Cancer Patients With Accuray Radixact System
News | Image Guided Radiation Therapy (IGRT) | July 03, 2017

July 3, 2017 — Accuray Inc. and Montefiore Einstein Center for Cancer Care (MECCC), part of the Montefiore Health...

IBA and Philips Step Up Commercial Collaboration in Brazilian Proton Therapy Market
News | Radiation Therapy | July 03, 2017

July 3, 2017 — IBA and Philips announced in mid-June they are stepping up their combined effort for...

ASTRO Names 2017 Gold Medalists in Radiation Oncology
News | Radiation Therapy | July 03, 2017

July 3, 2017 — The American Society for Radiation Oncology (ASTRO) announced the 2017 ASTRO Gold Medalists. Søren M...

Multiple Uses for Gamma Knife to Drive Market Growth Through 2025
News | Radiation Therapy | June 29, 2017

June 29, 2017 — Due to its widespread success in treating several types of brain cancer, global market growth for...

Augmenix Announces First New Zealand Prostate Cancer Patient Treated with SpaceOAR Hydrogel
News | Patient Positioning Radiation Therapy | June 28, 2017

June 28, 2017 — Augmenix Inc. announced that the first patient in New Zealand has been treated with SpaceOAR...

ASTRO Issues Guideline for Stereotactic Radiation Use in Early-Stage Lung Cancer
Feature | Lung Cancer | June 23, 2017

June 23, 2017 — The American Society for Radiation Oncology (ASTRO) recently issued a new clinical guideline for the...

University of Wisconsin-Madison Partners With RaySearch on RayCare OIS
News | Oncology Information Management Systems (OIMS) | June 21, 2017

June 21, 2017 — The Department of Human Oncology at the University of Wisconsin-Madison has entered into an...

IUCT Oncopole Installs First Radixact Radiotherapy System in France
News | Intensity Modulated Radiation Therapy (IMRT) | June 20, 2017

June 20, 2017 — Accuray Inc. announced that the University Cancer Institute of Toulouse Oncopole (IUCT Oncopole) in...

Henry Ford Cancer Institute First in World to Install Viewray MRIdian Linac
News | Image Guided Radiation Therapy (IGRT) | June 19, 2017

June 19, 2017 — The Henry Ford Cancer Institute is the first in Michigan – and first in the world – to offer...

stereotactic body radiation therapy (SBRT)
News | Stereotactic Body Radiation Therapy (SBRT) | June 12, 2017

The American Society for Radiation Oncology (ASTRO) issued a new clinical guideline for the use of...

News | Image Guided Radiation Therapy (IGRT) | May 24, 2017

May 24, 2017 — The University Medical Centre (UMC) Utrecht in the Netherlands recently treated the first patient as...

ASTRO's 59th Annual Meeting Will Explore Art and Science of Radiation Oncology
News | Radiation Therapy | May 19, 2017

May 19, 2017 — Registration has opened for the 59th Annual Meeting of the American Society for Radiation Oncology (...

Proton Monte Carlo Dose Calculation Now Part of RayStation Treatment Planning
News | Treatment Planning | May 15, 2017

May 15, 2017 — RaySearch demonstrated a new Monte Carlo dose planning feature for...

Accuray, CyberKnife system, SBRT, long-term disease control, prostate cancer, ASCO GU study
News | Radiation Therapy | February 17, 2017

February 17, 2017 — Accuray Inc. recently announced data from a prospective, Phase II, 17-center study which showed...

radiotargeted therapy, SST2 antagonists, combat cancer, neuroendocrine tumors, NETs, Journal of Nuclear Medicine study

Comparative receptor autoradiography in various cancer types (A = HE staining) with I-125-JR11 (B+C) and I-125-Tyr3-octreotide (D+E). B and D are the respective total binding, C and E the respective non-specific binding. Bars = 1 mm.

I: Breast cancer. II: Renal cell cancer. III: Medullary thyroid cancer. IV: Non-Hodgkin lymphoma. V: Colon cancer. In cancers I-V, the sections were incubated with 30’000 cpm/100 μl of antagonist or agonist. Cancers I-IV show a much higher density of sst2 with the antagonist. The colon cancer V is negative. VI: Ileal NET, incubated with 10’000 cpm/100 μl of antagonist or agonist. Credit: Jean Claude Reubi, Institute of Pathology, University of Berne, Berne, Switzerland. 

News | Radiation Therapy | February 06, 2017

February 6, 2017 — A study published in the February issue of...

Sponsored Content | Videos | Radiation Oncology | January 05, 2017

Join Chris Toth, president, Oncology Systems Americas, for a look at Varian’s new product introductions and major...